Regional variation in the use of medications by older Canadians—a persistent and incompletely understood phenomena
- 3 January 2003
- journal article
- research article
- Published by Wiley in Pharmacoepidemiology and Drug Safety
- Vol. 12 (7) , 575-582
- https://doi.org/10.1002/pds.803
Abstract
Background: We have previously reported on regional variability in medication consumption by older Canadians. In this study, we used longitudinal data to determine whether regional differences in commonly consumed medications persisted and to explore potential explanatory factors for observed differences.Methods: We utilized data from the second phase of the Canadian Study of Health and Aging to assess the number, types, and variability of medications used between regions. Linear and logistic regressions (LRs) were used to predict the number of medications and the use of specific agents where significant regional variability was found to exist.Results: There were significant regional differences in the number of medications consumed and in the prevalence of use of acetaminophen (p < 0.002), benzodiazepines (p < 0.020), nitrates (p = 0.040), and complementary and alternative medicines (CAMs; p < 0.020). The proportion of subjects using acetaminophen was highest in British Columbia (44.6%) and lowest in Quebec (27.3%). Benzodiazepine and nitrate consumption was highest in Quebec (35.9 and 19%, respectively) and lowest in the Praires (18.2%) and Atlantic Canada (6.6%). CAM use was highest in British Columbia (47.1%) and lowest in the Atlantic region (26.8%). Similar inter‐regional differences had been found 5 years previously. There were no significant regional differences in the prevalence of hypertension, myocardial infarction, diabetes, arthritis/rheumatism, or depression. Region remained a significant explanatory variable for the number of medications and nitrate, benzodiazepine, and CAM use in our multivariate models.Conclusions: Regional differences in medication use persisted over the course of this longitudinal study. Much of the variability remains unexplained. The reasons for regional differences in consumption of drugs and their clinical significance should be addressed. Copyright © 2003 John Wiley & Sons, Ltd.Keywords
This publication has 17 references indexed in Scilit:
- The use of alternative therapies by patients with Parkinson’s diseaseNeurology, 2001
- Geographic variation in incidence of coronary heart disease in Britain: the contribution of established risk factorsHeart, 2001
- Inter-Provincial Variation in Government Drug FormulariesCanadian Journal of Public Health, 2001
- Self-reported medication use for older people in England and WalesJournal of Clinical Pharmacy & Therapeutics, 2001
- The incidence of dementia in CanadaNeurology, 2000
- Geographic Variation in Stroke Risk in the United StatesStroke, 2000
- Complementary and alternative medicine use among elderly persons: one-year analysis of a Blue Shield Medicare supplementThe Journals of Gerontology: Series A, 2000
- Trends in Alternative Medicine Use in the United States, 1990-1997JAMA, 1998
- Regional differences in the characteristics and treatment of patients participating in an international heart failure trialJournal of Cardiac Failure, 1998
- Factors Underlying the Institutionalization of Elderly Persons in CanadaThe Journals of Gerontology, Series B: Psychological Sciences and Social Sciences, 1995